SBRI Healthcare

Presymptom Health is a medical technology company dedicated to advancing healthcare through the development of pre-symptomatic diagnostic tests and clinical decision support algorithms. The company focuses on creating innovative blood tests designed to detect illnesses at an early stage, particularly aiming to predict the onset of sepsis up to three days before symptoms manifest. By enabling earlier intervention, Presymptom Health seeks to improve critical care outcomes and enhance patient management, ultimately contributing to better survival rates and healthcare efficiency.

The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.

iPLATO is a healthcare technology company that develops myGP, a patient engagement platform aimed at enhancing access to healthcare services. The platform empowers patients by providing them with the necessary information to seek appropriate care, thereby reducing unnecessary appointments. By facilitating remote consultations, iPLATO enables healthcare professionals to make informed decisions in triaging patients and addressing their requests remotely. This innovative approach streamlines the patient experience and supports efficient healthcare delivery.

Upfront Diagnostics is a healthcare company focused on the development of innovative blood biomarkers aimed at enhancing medical diagnosis, particularly for stroke patients experiencing large vessel occlusions. By enabling rapid and precise identification of this stroke subtype, Upfront Diagnostics' biomarkers facilitate quicker treatment decisions by clinicians, paramedics, and nurses. This timely intervention is crucial for improving patient outcomes, as it can significantly reduce the time to treatment, thereby minimizing disabilities and fatalities associated with strokes. The company holds a portfolio of patents that safeguard its proprietary biomarkers, underscoring its commitment to advancing stroke care and improving overall healthcare efficiency.

Discover Momenta operates a digital health platform offering evidence-based, human-led therapeutic programs to prevent and manage lifestyle-related chronic diseases. Their services include cardiovascular disease prevention, diabetes remission and prevention, weight management, and smoking cessation, aiming to deliver scalable, flexible, and cost-effective solutions tailored to diverse communities and staff.

PocDoc is a digital health platform that specializes in the development of applications for the monitoring and testing of cardiovascular, metabolic, and renal diseases. The company's innovative platform integrates a smartphone app with a physical test chip, allowing users to obtain real-time analysis of lifestyle diseases. By measuring several key biomarkers from a single drop of blood, PocDoc enables individuals to gain comprehensive insights into their health. This approach not only facilitates full health assessments but also offers follow-on care pathways, empowering users to take control of their physical well-being.

Cardisio is a mobile health technology company specializing in non-invasive screening solutions for coronary and structural heart diseases. Its flagship product, the Cardisiography test, leverages artificial intelligence to analyze the heart's three-dimensional electrophysical profile, identifying pathological patterns associated with heart diseases. This early detection capability allows for preventive treatments, potentially averting fatal heart attacks. The testing process requires a PC to access the Cardisio Cloud, along with a data collector, such as a Cardisiograph, and standard ECG cables with disposable electrodes. By offering a convenient and accessible method for heart disease screening, Cardisio aims to reduce unnecessary cardiac-related complications and healthcare costs, ultimately improving patient outcomes.

The South West London Health and Care Partnership is comprised of the organizations providing health and care in the six southwest London boroughs. They have been listening to local people and our partners to collectively develop our vision for people. The awarding of ICS status recognizes the strength of our partnership, the shared ambitions for our six boroughs, and the significant progress we have made together over the last three years to deliver better outcomes for local people. Over the last few months, they have seen very real benefits of our partnership working well as they have responded together as a health and care system to the challenges of the coronavirus pandemic. To maintain and build on the South West London Health and Care Partnership vision for local people, we are working with partners at the local level to adapt this so we can continue to provide safe services and manage COVID-19 in our communities and organizations.The South West London Health and Care Partnership is comprised of the organisations providing health and care.

Health Fabric provides digital health solutions to enable better health and wellness.

Walk With Path specializes in developing wearable products that enhance mobility and provide therapeutic benefits for patients. The company's primary offering is a smart insole equipped with biofeedback and sensors, specifically designed to assist individuals with diabetes in improving balance and preventing foot ulcers. One of their key innovations, the Path Finder, is a medical device aimed at helping individuals with Parkinson's disease manage 'freezing of gait,' a condition where patients feel momentarily stuck. This product has shown efficacy through published evidence in Neurology. Walk With Path also offers data insights and analytics for both end users and healthcare professionals, making their products applicable for daily use and gait analysis in clinical and non-clinical settings.

Alvie Health is a company that specializes in providing health coaching and expert support aimed at enhancing the well-being of patients, particularly those undergoing treatment for cancer and surgery. It has developed a digitally-enabled behavior change platform that focuses on improving clinical outcomes and quality of life for patients. By utilizing personalization algorithms, the platform creates risk-stratified, clinically proven rehabilitation programs tailored to individual needs. These programs support patients on elective care pathways by tracking health behaviors, logging symptoms, and integrating behavior change principles, ultimately facilitating efficient and high-quality health outcomes.

Healum develops AI-powered collaborative software that empowers individuals with long-term conditions to monitor and understand their physical and mental health. The platform uses data-driven insights and evidence-backed interventions to support patients and facilitate personalized care.

My Mhealth is a developer of a digital health platform focused on managing long-term conditions through clinically-proven digital therapeutics. The company has created a web-based self-management program specifically for chronic obstructive pulmonary disease (COPD) and offers a multi-morbidity platform that addresses various long-term health issues. This innovative service enables healthcare providers to efficiently meet the needs of patients by scaling their services without requiring additional investments in staff, multiple platforms, or extensive infrastructure. By leveraging technology, My Mhealth aims to improve patient outcomes and streamline healthcare delivery for both patients and clinicians.

Aseptika Ltd., founded in 2007 and based in Huntingdon, United Kingdom, is a healthcare company specializing in the development and marketing of self-monitoring devices and services. These products are designed to help consumers and their healthcare providers manage long-term health conditions effectively. Aseptika offers a range of devices including activity trackers, body analyzers, blood pressure monitors, pulse oximeters, peak flow meters, POGO USB hubs, contactless thermometers, and more. Additionally, the company provides health monitoring applications, food diary apps, clinical applications for lung health management, and software for various platforms. These products are utilized for self-monitoring, biomarker tests, staying connected, clinical trials, corporate wellness programs, and healthcare collaborations. Aseptika's devices are distributed through a network of distributors.

Cyted Health specializes in developing a digital diagnostic infrastructure aimed at the early detection of diseases, particularly cancer. By leveraging artificial intelligence and innovative biomarkers, Cyted's platform enhances clinical insights and facilitates improved patient outcomes. The company's mission is to transform diagnostic methodologies, focusing on prevention rather than treatment, thereby contributing to a healthcare landscape where diseases are identified and addressed at their earliest stages.

Founded in London in 2013, MediShout develops a cloud-based digital platform that enhances operational efficiencies within healthcare settings. Its technology connects staff, systems, machines, and workflows, improving efficiency and patient care. The platform offers features such as two-way conversations, instant feedback, integration of logistical departments, and AI-driven predictive analytics.

Concentric Health is a company focused on transforming health decision-making through its innovative e-consent application. The application enhances efficiency by addressing backlog issues and minimizing medico-legal risks through the use of trusted content. It aims to simplify complex processes for both patients and clinicians, fostering shared decision-making that is informed by patient outcomes. By providing a secure and auditable platform, Concentric Health improves the overall experience for users, ultimately leading to better health outcomes.

Brain in Hand is a company that specializes in assistive technology aimed at enhancing independent living for individuals with neurological conditions. Founded in 2009 by Andrew Stamp and Tony Brown, and based in Exeter, United Kingdom, Brain in Hand develops software designed to assist users with autism spectrum disorders, brain injuries, and mental health challenges. Their flagship product, Brain-in-Hand Resolution, provides a personalized approach by analyzing users' daily activities and the potential issues they may encounter. The software is compatible with various mobile platforms, including Windows Mobile, iPhone, and Android devices. By serving a diverse range of sectors, including education, healthcare, social care, criminal justice, and advocacy, Brain in Hand enables organizations to better support individuals, improving engagement and self-management while alleviating anxiety associated with daily challenges.

Remcare facilitates remote collection of clinical data and patient communication via a smartphone app, enabling healthcare organizations to monitor patients' health status in real-time. It automates risk stratification, encourages patient self-management, and reduces the need for in-person appointments.

PinPoint Data Science, established in 2016 and headquartered in Leeds, United Kingdom, specializes in developing technology for early cancer detection. The company focuses on creating a test that employs machine learning to integrate data from various cancer biomarkers and patient information, aiming to enhance the accuracy of cancer diagnosis at an early stage.

52 North Health is a medical technology company focused on enhancing healthcare outcomes for cancer patients. It specializes in an AI-driven, portable finger prick blood test that measures neutrophil count and C-reactive protein (CRP) levels at home. This enables early detection of neutropenic sepsis risk during chemotherapy, improving patient safety and quality of life. The device facilitates timely management of the condition, offering a reliable and cost-effective solution for both patients and healthcare providers.

NeuroResponse is a healthcare company that provides patients with Multiple Sclerosis necessary access to clinicians to obtain medications.

Cyted Health specializes in developing a digital diagnostic infrastructure aimed at the early detection of diseases, particularly cancer. By leveraging artificial intelligence and innovative biomarkers, Cyted's platform enhances clinical insights and facilitates improved patient outcomes. The company's mission is to transform diagnostic methodologies, focusing on prevention rather than treatment, thereby contributing to a healthcare landscape where diseases are identified and addressed at their earliest stages.

Remcare facilitates remote collection of clinical data and patient communication via a smartphone app, enabling healthcare organizations to monitor patients' health status in real-time. It automates risk stratification, encourages patient self-management, and reduces the need for in-person appointments.

Founded in London in 2013, MediShout develops a cloud-based digital platform that enhances operational efficiencies within healthcare settings. Its technology connects staff, systems, machines, and workflows, improving efficiency and patient care. The platform offers features such as two-way conversations, instant feedback, integration of logistical departments, and AI-driven predictive analytics.

Brain in Hand is a company that specializes in assistive technology aimed at enhancing independent living for individuals with neurological conditions. Founded in 2009 by Andrew Stamp and Tony Brown, and based in Exeter, United Kingdom, Brain in Hand develops software designed to assist users with autism spectrum disorders, brain injuries, and mental health challenges. Their flagship product, Brain-in-Hand Resolution, provides a personalized approach by analyzing users' daily activities and the potential issues they may encounter. The software is compatible with various mobile platforms, including Windows Mobile, iPhone, and Android devices. By serving a diverse range of sectors, including education, healthcare, social care, criminal justice, and advocacy, Brain in Hand enables organizations to better support individuals, improving engagement and self-management while alleviating anxiety associated with daily challenges.

IbisVision Limited is a company that specializes in developing visual field test software aimed at the early detection of glaucoma, a leading cause of blindness. Its flagship product, Ring of Sight, utilizes patented technology to offer a unique eye testing experience through a cloud-based application that can be accessed remotely from various locations. The software consolidates multiple eye tests into one device, allowing healthcare professionals to conduct both in-practice and no-contact testing. This innovative approach not only enhances patient care but also supports optometrists in maximizing operational efficiency. Founded in 2013 and located in Livingston, United Kingdom, IbisVision is committed to improving eye care by providing a reliable and secure platform for diagnosing and monitoring glaucoma. The application ensures data privacy through secure encrypted servers, underscoring the company's dedication to maintaining high standards of patient confidentiality and security.

Evolv Rehabilitation Technologies S.L. is a company focused on developing software and hardware medical devices that specialize in rehabilitation technologies, particularly for neurorehabilitation, orthopedic rehabilitation, and geriatric care. The company has created VirtualRehab, a cloud-based tele-rehabilitation platform that incorporates virtual reality, motion capture systems, and gamification to enhance traditional therapy methods. Established in 2017, Evolv is headquartered in Basauri, Spain.

Upfront Diagnostics is a healthcare company focused on the development of innovative blood biomarkers aimed at enhancing medical diagnosis, particularly for stroke patients experiencing large vessel occlusions. By enabling rapid and precise identification of this stroke subtype, Upfront Diagnostics' biomarkers facilitate quicker treatment decisions by clinicians, paramedics, and nurses. This timely intervention is crucial for improving patient outcomes, as it can significantly reduce the time to treatment, thereby minimizing disabilities and fatalities associated with strokes. The company holds a portfolio of patents that safeguard its proprietary biomarkers, underscoring its commitment to advancing stroke care and improving overall healthcare efficiency.

Newcastle Hospitals NHS Foundation Trust is one of the busiest, largest and most successful teaching NHS foundation trusts in the country. They support people with a range of rare and complex medical, surgical and neurological conditions, cancers and genetic orders. These include a range of flagship services which deliver cutting-edge care and are a catalyst for innovation to support pioneering clinical practice in the NHS.

52 North Health is a medical technology company focused on enhancing healthcare outcomes for cancer patients. It specializes in an AI-driven, portable finger prick blood test that measures neutrophil count and C-reactive protein (CRP) levels at home. This enables early detection of neutropenic sepsis risk during chemotherapy, improving patient safety and quality of life. The device facilitates timely management of the condition, offering a reliable and cost-effective solution for both patients and healthcare providers.

Invitron is a biotechnology company with specialist expertise in the development and manufacture of high sensitivity in-vitro diagnostics.

Stream Bio is a nanotechnology research company focused on designing, developing, and manufacturing bioimaging probes. These probes are intended to cover the visible and near-infrared spectrum, making them suitable for applications in research and development, in-vitro diagnostic assays, and therapeutic research. The company aims to create high-sensitivity quantitative and rapid point-of-care lateral flow diagnostic tests, with a particular focus on indicators of heart attacks. Stream Bio leverages its expertise in both science and business to provide solutions across various strands of the life sciences industry.

Invitron is a biotechnology company with specialist expertise in the development and manufacture of high sensitivity in-vitro diagnostics.

Brain in Hand is a company that specializes in assistive technology aimed at enhancing independent living for individuals with neurological conditions. Founded in 2009 by Andrew Stamp and Tony Brown, and based in Exeter, United Kingdom, Brain in Hand develops software designed to assist users with autism spectrum disorders, brain injuries, and mental health challenges. Their flagship product, Brain-in-Hand Resolution, provides a personalized approach by analyzing users' daily activities and the potential issues they may encounter. The software is compatible with various mobile platforms, including Windows Mobile, iPhone, and Android devices. By serving a diverse range of sectors, including education, healthcare, social care, criminal justice, and advocacy, Brain in Hand enables organizations to better support individuals, improving engagement and self-management while alleviating anxiety associated with daily challenges.

getUBetter is a digital health company specialising in musculoskeletal conditions. It offers a platform that empowers patients to manage their recovery and prevention of common injuries and conditions, such as back, leg, neck, shoulder, knee, and ankle pain. The platform provides evidence-based support, aiming to avoid care silos and reduce over-treatment, thereby promoting more efficient use of healthcare resources.

Zilico Limited is a medical diagnostics company focused on developing innovative devices for cancer detection, particularly cervical cancer. Founded in 2006 and based in Manchester, United Kingdom, with an additional office in Sheffield, Zilico utilizes electrical impedance spectroscopy technology to enhance diagnostic accuracy and provide real-time results. Its primary product, ZedScan, is designed to assess cervical epithelial tissue objectively during colposcopy, thereby reducing the subjectivity associated with traditional diagnostic methods. The company is advancing its offerings with two applications aimed at improving referral and screening processes for neoplastic conditions. By enhancing the ability to detect cervical intraepithelial neoplasia, Zilico aims to support healthcare professionals in delivering better diagnostic accuracy and optimizing cancer screening programs.

BIOS Health is a pioneering company focused on developing neural digital therapies by harnessing data-driven insights from the human nervous system. Co-founded by researchers from Cambridge University, the firm aims to revolutionize precision medicine through the identification of neural biomarkers that link nerve activity to various medical conditions. BIOS's innovative approach holds promise for treating chronic diseases such as hypertension, diabetes, rheumatoid arthritis, and neurodegenerative disorders like Parkinson's and Alzheimer's. The company's expertise encompasses a diverse range of fields, including neuroscience, machine learning, software engineering, and biotechnology, allowing it to create advanced solutions for improving the quality of life for individuals suffering from these conditions. Additionally, BIOS is engaged in developing prosthetic connectors that standardize the interface between bionic devices and the body's nervous and soft-tissue systems, enabling enhanced control and feedback for patients with prosthetics.

MediSieve Ltd. is a London-based medical device company specializing in Magnetic Blood Filtration (MBF) technology aimed at treating blood-borne diseases. Founded in 2014, the company has developed a system that utilizes a magnetic filter to physically remove infected blood cells from a patient's bloodstream. The process involves circulating blood through an external loop where targeted magnetic particles are infused, binding to disease-relevant targets. This filtered blood then passes through a magnetic filter that captures the particles and bound targets, allowing the unaffected blood to return to the patient without the particles entering their body. MediSieve's innovative approach is applicable to various conditions, including malaria, leukaemia, sepsis, and other blood-borne diseases, enhancing the efficacy and safety of existing therapies. The company operates out of the Imperial Incubator in White City, London, where it conducts product development and validation in its dedicated laboratory facilities.

Mayden specializes in developing and managing cloud-based software solutions for the healthcare sector. They offer a range of services including patient management systems, operational management tools, online service assessment platforms, and secure hosting solutions. With offices near Bath and Chippenham, Mayden employs around 45 staff and associates, driven by a mission to enhance healthcare services through innovative technology.

Mayden specializes in developing and managing cloud-based software solutions for the healthcare sector. They offer a range of services including patient management systems, operational management tools, online service assessment platforms, and secure hosting solutions. With offices near Bath and Chippenham, Mayden employs around 45 staff and associates, driven by a mission to enhance healthcare services through innovative technology.

Oncimmune (USA) LLC, founded in 2006, is a leader in early cancer detection, operating as a subsidiary of Oncimmune LTD based in Nottingham, England. The company specializes in developing proprietary autoantibody assay technologies to identify over 90 percent of solid-tumor cancers, which account for 70 percent of all cancer cases, including those of the lung, breast, colorectal, prostate, stomach, pancreatic, and ovarian cancers. Under the guidance of Dr. John Robertson, the chief scientific officer, Oncimmune focuses on research and development to enhance its diagnostic capabilities. The company's laboratory in metro Kansas City is CLIA-certified, ensuring compliance with regulatory standards for laboratory testing. Oncimmune holds a portfolio of patents that supports its innovative approaches in personalized immunodiagnostics, aimed at improving cancer screening, detection, and patient care.

Corporate Health creating highly automated, primary-care delivered video capsule endoscopy diagnostics.

Isobar Compression is a manufacturer specializing in exact-fit compression garments designed to treat chronic venous insufficiency, aid in sports recovery, and prevent deep vein thrombosis (DVT). Utilizing advanced technology, the company creates compression socks that are tailored to the unique shape and size of an individual’s limbs through a 3D scanning process. This bespoke fitting ensures that the garments deliver precise pressure, significantly reducing the risk of DVT, particularly for frequent and long-haul flyers. Developed by a research team at Manchester University, led by Professor Charles McCollum, a leading vascular surgeon, Isobar's products are proven to be more effective than standard off-the-shelf options. The effectiveness of Isobar's compression garments has been validated through research, demonstrating their benefits in reducing muscle soreness for athletes, with many medal-winning British Olympic athletes using them for post-exercise recovery. The company is increasingly recognized for its innovative approach to mitigating health risks associated with prolonged travel and enhancing athletic performance.

Corporate Health creating highly automated, primary-care delivered video capsule endoscopy diagnostics.

Oncimmune (USA) LLC, founded in 2006, is a leader in early cancer detection, operating as a subsidiary of Oncimmune LTD based in Nottingham, England. The company specializes in developing proprietary autoantibody assay technologies to identify over 90 percent of solid-tumor cancers, which account for 70 percent of all cancer cases, including those of the lung, breast, colorectal, prostate, stomach, pancreatic, and ovarian cancers. Under the guidance of Dr. John Robertson, the chief scientific officer, Oncimmune focuses on research and development to enhance its diagnostic capabilities. The company's laboratory in metro Kansas City is CLIA-certified, ensuring compliance with regulatory standards for laboratory testing. Oncimmune holds a portfolio of patents that supports its innovative approaches in personalized immunodiagnostics, aimed at improving cancer screening, detection, and patient care.

Healthera Ltd., established in 2015 and headquartered in Cambridge, UK, specializes in developing digital health solutions. Its flagship product, Healthera, is a pharmacy-integrated medication management app that offers automatic prescription reminders, smart labelling, scheduling, health condition tracking, and professional advice from pharmacists. Additionally, Healthera operates a healthcare marketplace that connects patients with local pharmacies and GPs, enabling faster medicine delivery and personalized care. The company partners with over 1000 pharmacies and Clinical Commissioning Groups (CCGs) across the UK, reaching over 20 million people. Healthera's technology is accredited by NHS Digital and aims to improve prescribing efficiency, patient experience, and reduce wastage within the NHS.

Doc Abode is a technology company focused on improving healthcare delivery by connecting patients with local clinicians for home-based care. Its innovative platform facilitates workforce management by allowing clinicians to set their availability, which enhances the responsiveness and efficiency of healthcare services. By expanding access to a flexible workforce, Doc Abode aims to improve operational resilience within healthcare systems, reduce clinical risks, and minimize unnecessary hospital visits. The company is dedicated to creating safer and faster healthcare solutions tailored to individual patient needs.

MyWay Digital Health is a global digital platform empowering individuals with long-term conditions, particularly diabetes, to self-manage their health. It offers personalized advice, educational resources, and access to health records via its user-friendly interface. Clinicians benefit from population analytics tools for improved decision support.

iPLATO is a healthcare technology company that develops myGP, a patient engagement platform aimed at enhancing access to healthcare services. The platform empowers patients by providing them with the necessary information to seek appropriate care, thereby reducing unnecessary appointments. By facilitating remote consultations, iPLATO enables healthcare professionals to make informed decisions in triaging patients and addressing their requests remotely. This innovative approach streamlines the patient experience and supports efficient healthcare delivery.

Healum develops AI-powered collaborative software that empowers individuals with long-term conditions to monitor and understand their physical and mental health. The platform uses data-driven insights and evidence-backed interventions to support patients and facilitate personalized care.

Orsus Medical, established in 2015 and headquartered in Chepstow, UK, specializes in the manufacture and distribution of wristband sensors. These sensors are designed to non-invasively monitor blood glucose levels in real-time and continuously, targeting the diabetic population. The company operates as a subsidiary of Afon Technology Limited.

Saccade Diagnostics brings to market for the first time clinically-validated objective tests to help clinicians with diagnostic evaluation and management of psychiatric disorders in patients with mental health complaints. A spin-out from the University of Aberdeen, Saccade has devised a rapid eye-movement test called SaccScan that can help medical professionals diagnose a range of psychiatric disorders, such as schizophrenia, bipolar disorder and major depression within just 30 minutes. It is non-invasive, affordable and easy to administer, allowing non-specialists to operate it with minimal training. The academic founders, Philip Benson and David St Clair, teamed up with Madhu Nair, who took on the role of commercial champion and CEO.

Ulsys is interactive venous leg ulcer self-care system with remote GP access.

Founded in 2008, Manus Neurodynamica specializes in medical diagnostic technologies for neuromotor impairments. Its primary product is a non-invasive device designed to support early diagnostics and monitoring of Parkinson's disease, with applications in academic research, pharmaceutical studies, and non-medical uses.

Digital Algorithms primary care will look very different in the near future.

​Brainminer Ltd has developed an automated system for analysing MR brain scans. Brainminer was founded in 2015 by the Academic inventors and UCLB, the business arm of University College London, with the purpose of commercialising the exciting new machine learning algorithms that have been created for brain analysis at UCL and elsewhere. You can find out more about the company's foundation here. The company has received over £1M of funding from 2 SBRI awards in 2015 and 2016. The company’s first product, DIADEM, is CE marked and medically approved.

MicroBioSensor is a diagnostics company that specializes in developing disposable point-of-care medical devices for the early detection of bacterial infections. Its products are designed to be user-friendly and accessible for untrained personnel in various healthcare settings, including care homes, pharmacies, and general practice offices. The company focuses on providing solutions for early infection detection in patients undergoing peritoneal dialysis and for identifying urinary tract infections, including antibiotic selection. By embedding its tests in existing medical devices such as dialysis equipment and wound dressings, MicroBioSensor aims to enhance patient care through timely interventions at a cost-effective price.

PolyPhotonix is a bio-photonic company focused on research, development, and manufacture of non-invasive light therapy medical devices. It designs and produces home care products that apply light therapy to treat eye diseases such as macular degeneration and diabetic retinopathy. The company collaborates with designers and key customers to advance products from concept through manufacturing and is based at the National Printable Electronics Centre.

DynamX Medical is a healthcare technology company that has created an innovative precancer screening system designed for rapid tissue biopsy analysis. This system is user-friendly and can be operated at the point of care by nurses, enhancing accessibility and efficiency in medical settings. The company's software aims to streamline disease diagnosis by increasing the speed and reliability of detection, thereby alleviating the workload on healthcare institutions. Through its novel technology, DynamX Medical seeks to improve diagnostic processes, ultimately supporting better patient outcomes and reducing the strain on healthcare resources.

Sepsis Ltd has developed a new test for detecting infection and inflammation which is ready for license and final development/transfer to manufacturing

Andiamo is a custom medical wearables platform that focuses on providing innovative solutions for neuromuscular conditions, beginning with cerebral palsy. The company operates a digital clinic that connects families with specialists, ensuring they receive the necessary care and expertise when and where it is needed. By leveraging technology, Andiamo aims to improve the quality of life for individuals with neuromuscular disorders through tailored wearable devices and specialized medical services.

Aseptika Ltd., founded in 2007 and based in Huntingdon, United Kingdom, is a healthcare company specializing in the development and marketing of self-monitoring devices and services. These products are designed to help consumers and their healthcare providers manage long-term health conditions effectively. Aseptika offers a range of devices including activity trackers, body analyzers, blood pressure monitors, pulse oximeters, peak flow meters, POGO USB hubs, contactless thermometers, and more. Additionally, the company provides health monitoring applications, food diary apps, clinical applications for lung health management, and software for various platforms. These products are utilized for self-monitoring, biomarker tests, staying connected, clinical trials, corporate wellness programs, and healthcare collaborations. Aseptika's devices are distributed through a network of distributors.

Safekeeping LLC is a healthcare technology company established in 2015 and headquartered in Evansville, Indiana. It specializes in developing a patient engagement and communication portal designed for long-term care facilities. The core product, SafeKeeping, serves as a care dashboard that securely shares electronic medical record (EMR) data with residents, their families, and caregivers. This platform aims to enhance health outcomes by facilitating better coordination of care among stakeholders, improve facility ratings through increased family satisfaction, and optimize reimbursement strategies.

Folium Optics, established in 2013 by Steve Kitson and John Rudin, specializes in developing electronic devices to enhance medication adherence. The company's primary product is a wireless tag attached to medical packaging, connected to a remote cloud service, and a portable reminder unit. This system allows pharmacists, caregivers, and users to effectively manage and monitor medication intake. Folium Optics operates from an industrial unit in Thornbury, Bristol, equipped with an advanced cleanroom for product development and prototyping, and employs a team of scientists, engineers, and management professionals.

Oxford Medical Diagnostics develops laser-based technology for the analysis of gases. The company focuses on developing a platform for detecting minute quantities of markers in exhaled breath.

CareflowConnect creates a real-time clinical communications network which transforms how healthcare teams work together to improve patient safety and outcomes.

Healthera Ltd., established in 2015 and headquartered in Cambridge, UK, specializes in developing digital health solutions. Its flagship product, Healthera, is a pharmacy-integrated medication management app that offers automatic prescription reminders, smart labelling, scheduling, health condition tracking, and professional advice from pharmacists. Additionally, Healthera operates a healthcare marketplace that connects patients with local pharmacies and GPs, enabling faster medicine delivery and personalized care. The company partners with over 1000 pharmacies and Clinical Commissioning Groups (CCGs) across the UK, reaching over 20 million people. Healthera's technology is accredited by NHS Digital and aims to improve prescribing efficiency, patient experience, and reduce wastage within the NHS.

Current Health Limited is a healthcare technology company based in Edinburgh, United Kingdom, that specializes in wearable devices for monitoring patient vitals. Founded in 2014 and originally known as Snap40 Limited, the company rebranded in December 2018. Current Health's devices are designed to measure critical health indicators such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, enabling early identification of potential health issues. Their patient monitoring platform facilitates the management of patients at home by collecting and analyzing data to detect and predict health deterioration. This allows patients to share daily activities, report symptoms, and complete structured questionnaires, ultimately helping healthcare providers reduce risks and costs associated with patient care.

Sky Medical Technology Limited is a biomedical device company based in High Wycombe, United Kingdom, specializing in neuromuscular electro-stimulation medical devices. Founded in 2006, the company has developed innovative products such as the geko device, which stimulates the common peroneal nerve to enhance venous blood flow, and the firefly device, designed to aid professional athletes in muscle recovery by improving lower limb circulation. The company’s OnPulse™ technology represents a significant advancement in bioelectronic compression therapy, offering clinically proven solutions for preventing and treating various circulatory conditions, including life-threatening blood clots, post-surgical swelling, and non-healing wounds. Sky Medical Technology's products cater to a range of medical applications and are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, in both clinical practice and studies. The company distributes its devices internationally across multiple regions, including Asia, Europe, and North America.

Rinicare Ltd. is a healthcare technology company based in Macclesfield, United Kingdom, specializing in the design and manufacture of innovative monitoring devices. The company offers a range of products, including the PRIME device, which utilizes wireless sensors for vital sign monitoring and data analysis, allowing clinicians to remotely visualize, transmit, and store patient data. Additionally, Rinicare has developed PRIME IoT, which facilitates the transmission of vital sign data to compatible devices through healthcare application software. The company also focuses on patient safety with its SAFE system, a falls detection and prevention solution that employs thermal imaging sensors and intelligent algorithms to monitor patients' positions in bed, alerting clinicians to potential fall risks. Through these technologies, Rinicare aims to enhance patient care by providing real-time insights that support informed decision-making in clinical settings. Established in 2002, Rinicare continues to innovate within the healthcare sector.

11 Health is a healthcare company founded by Michael Seres, an innovator with personal experience as an ostomy patient. Diagnosed with Crohn’s Disease at the age of 12, Seres underwent numerous medical procedures, including a small bowel transplant, which inspired him to create solutions for others in similar situations. The company has developed a virtual healthcare ecosystem that provides an integrated care experience for ostomy patients. This ecosystem includes a range of products and services aimed at connecting patients with their medical teams, facilitating recovery after transplantation, and reducing hospital readmissions for ileostomy patients. Through its innovative approach, 11 Health seeks to improve the quality of care and support for individuals living with ostomies.

Mayden specializes in developing and managing cloud-based software solutions for the healthcare sector. They offer a range of services including patient management systems, operational management tools, online service assessment platforms, and secure hosting solutions. With offices near Bath and Chippenham, Mayden employs around 45 staff and associates, driven by a mission to enhance healthcare services through innovative technology.

JVS Products development of a simple, one-step cleaning method for intermittent catheters to enable frail.

Lucid aims to develop a unique 3 in one diagnostic device. The device would help intuitive, fast and economic measure biophysiological markers (pressure, sensation and muscle contractility – via EMG), enabling more precise diagnosis of the functional deficits in faecal incontinence at primary care.

PolyPhotonix is a bio-photonic company focused on research, development, and manufacture of non-invasive light therapy medical devices. It designs and produces home care products that apply light therapy to treat eye diseases such as macular degeneration and diabetic retinopathy. The company collaborates with designers and key customers to advance products from concept through manufacturing and is based at the National Printable Electronics Centre.

Isansys Lifecare is a digital healthcare company that has developed a patient status engine and a user-friendly, sophisticated patient monitoring platform. The PSE automates fundamental healthcare procedures. They focused on developing new patient-centered technology and data-driven methods in hospitals and healthcare organizations throughout the world.

Peacocks Medical Group is foot orthotic optimisation via finite element analysis and additive manufacturing.

Owlstone Medical develops and commercializes breathalyzers for clinical diagnostics and precision medicine. Its products detect volatile organic compounds in breath samples to diagnose diseases like lung cancer, asthma, and tuberculosis. The company has strategic collaborations with pharmaceutical companies and is based in Cambridge, UK.

Ulsys is interactive venous leg ulcer self-care system with remote GP access.

Inspiration Healthcare is a global supplier of medical technology specializing in critical care, operating theatre, and home healthcare applications. The company is dedicated to providing innovative and high-quality products that enhance patient outcomes and improve the efficiency of healthcare organizations. Its portfolio includes critical care solutions such as non-invasive respiratory management, thermoregulation, diagnostics, and patient warming devices tailored for patients ranging from newborns to adults in intensive care and operating rooms. Additionally, Inspiration Healthcare distributes products that support specialized surgical procedures and infusion therapies. The majority of its revenue is generated in the United Kingdom, primarily from its critical care market division.

Message Dynamics is a company that specializes in patient messaging services aimed at enhancing medication compliance and overall patient care. The organization offers telehealth services utilizing various communication channels, including automated voice calls, SMS, email, and smartphone applications. Additionally, Message Dynamics provides support in multiple languages to cater to a diverse patient population. By leveraging these technologies, the company seeks to reduce hospital admissions and promote better health outcomes for patients while maintaining cost-effectiveness. Its solutions have been successfully implemented by healthcare systems, including the NHS, demonstrating their effectiveness in improving patient engagement and adherence to prescribed therapies.

Founded by a consultant ENT surgeon and designer entrepreneur, Cupris Ltd develops smartphone-connected medical devices for remote healthcare. Its flagship product is TYM, a smart otoscope that captures images and videos of the ear, enabling secure sharing via encrypted email. The company ensures data compliance with NHS standards.

Sensixa Ltd is a London-based company, established in 2006 as a spin-off from the Hamlyn Centre at Imperial College London. The company specializes in the manufacture of advanced wireless sensing devices designed for accurate physical activity monitoring. Sensixa focuses on developing wearable and implantable technologies aimed at healthcare, wellbeing, sports, and gaming applications. Its innovative solutions provide a personalized monitoring platform that is intelligent, context-aware, and minimally intrusive, allowing for natural behaviors without restrictions. The company's expertise lies in low-power micro-electronics, sensor analytics, and behavior profiling. Among its products is an in-ear health monitoring system that transmits vital health information to connected devices, enabling healthcare professionals to assess various physical metrics, including gait, locomotion, and shock wave transmission.

Selective Antibodies Ltd is a UK based diagnostics company with the prime focus of overcoming key technological problems central to the production of high performance point of needs systems for small target molecules such as: medicaments, natural and unnatural toxins (such as fungal toxins and pesticides), drugs of abuse, CBRNE substances, and other substances of importance to forensic investigation, the environmental and food and water industries. It has met this overall target by developing new technology that can be applied across the board - from high throughput analysers to very simple to use point of need applications.

Biovici is currently developing the next generation of Point-of-Care diagnostic devices.

Peacocks Medical Group is foot orthotic optimisation via finite element analysis and additive manufacturing.

CFT is developing affordable microfluidics for rapid, sensitive, point of care measurement of multiple cardiovascular disease biomarkers.

Dorset Mental Health Forum developing Moodbase, a tool for people who are suffering from mental health and wellbeing issues.

Aseptika Ltd., founded in 2007 and based in Huntingdon, United Kingdom, is a healthcare company specializing in the development and marketing of self-monitoring devices and services. These products are designed to help consumers and their healthcare providers manage long-term health conditions effectively. Aseptika offers a range of devices including activity trackers, body analyzers, blood pressure monitors, pulse oximeters, peak flow meters, POGO USB hubs, contactless thermometers, and more. Additionally, the company provides health monitoring applications, food diary apps, clinical applications for lung health management, and software for various platforms. These products are utilized for self-monitoring, biomarker tests, staying connected, clinical trials, corporate wellness programs, and healthcare collaborations. Aseptika's devices are distributed through a network of distributors.

St George's, University of London is an independent institution focused on medical and healthcare education. It operates as a university that brings together a diverse community of scientists, students, doctors, nurses, psychologists, midwives, physiotherapists, radiographers, and administrators. The university is dedicated to addressing healthcare needs and challenges through research and study in various healthcare topics. By fostering an environment that encourages practical application of knowledge in the field of medicine, St George's aims to enhance the quality of healthcare education and contribute to advancements in the medical sector.

My Mhealth is a developer of a digital health platform focused on managing long-term conditions through clinically-proven digital therapeutics. The company has created a web-based self-management program specifically for chronic obstructive pulmonary disease (COPD) and offers a multi-morbidity platform that addresses various long-term health issues. This innovative service enables healthcare providers to efficiently meet the needs of patients by scaling their services without requiring additional investments in staff, multiple platforms, or extensive infrastructure. By leveraging technology, My Mhealth aims to improve patient outcomes and streamline healthcare delivery for both patients and clinicians.

Veraz is a developer of medical technology focused on enhancing healthcare practices through innovative monitoring solutions. The company creates products that assist businesses in ensuring compliance with best practice protocols among their staff. Veraz specializes in a touch-based healthcare system that enables instant and accurate monitoring of critical practices, such as hand washing and physical contact with patients and their environment. By doing so, the company helps medical practitioners detect lapses in healthcare provision, ultimately aiming to reduce the risk of infection spread in clinical settings.

Vitalpac a System C company, is a healthcare improvement organisation. Vitalpac apply clinical insight to develop tools that help clinicians deliver better and safer patient care. We focus on gathering data through routine clinical processes then reapplying it to improve outcomes for patients. Vitalpac support clinicians by providing tools they can carry in their pocket that help them carry out their roles more effectively, reducing the opportunity for error and providing instant access to critical information through simple, clear interfaces.

SilverCloud Health, established in 2011, is a digital health company that develops and provides online therapeutic solutions via tailored clinical programs. Headquartered in Boston, Massachusetts, with offices in Dublin, Ireland, and London, UK, the company's SilverCloud platform offers evidence-based, supported digital therapies to various healthcare sectors. It aims to increase client/patient engagement and reduce program dropout rates, as demonstrated by a three-fold improvement in these metrics compared to leading online therapeutic products.

Glyconics Ltd. is a diagnostics company based in Cambridge, United Kingdom, that specializes in developing portable infrared spectroscopy devices for the diagnosis and monitoring of chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Founded in 2013, Glyconics has created a hand-held miniaturized device that allows patients to conduct tests at home by analyzing sputum samples for specific biomarkers associated with COPD. Utilizing Fourier transform infrared spectroscopy, the device identifies spectral waves to provide detailed insights into the composition of the samples, facilitating early detection and monitoring of exacerbations in patients with suspected respiratory diseases.

Ieso Digital Health provides online, evidence-based mental health therapy via a digital platform, enabling one-to-one cognitive behavioral therapy delivered by accredited therapists in a virtual, convenient setting. The service covers common mental health conditions such as anxiety, depression, OCD, PTSD, sleep problems, and related issues, and also supports patients with chronic physical health problems, medically unexplained symptoms, and other cognitive concerns. The company uses proprietary technology, including natural language processing and artificial intelligence, to monitor therapist protocol adherence and risk in real time, enabling text-based therapy sessions. It serves health providers including the NHS, private individuals, and employers, expanding access to clinically validated care outside traditional in-person settings.

Founded in London in 2012, DrDoctor specializes in cloud-based patient management tools. Its platform enables patients to access bookings, care plans, test results, and hospital information, facilitating online appointment management via mobile or text. This empowers hospitals to enhance communication methods and puts patients at the forefront of their healthcare.

Ieso Digital Health provides online, evidence-based mental health therapy via a digital platform, enabling one-to-one cognitive behavioral therapy delivered by accredited therapists in a virtual, convenient setting. The service covers common mental health conditions such as anxiety, depression, OCD, PTSD, sleep problems, and related issues, and also supports patients with chronic physical health problems, medically unexplained symptoms, and other cognitive concerns. The company uses proprietary technology, including natural language processing and artificial intelligence, to monitor therapist protocol adherence and risk in real time, enabling text-based therapy sessions. It serves health providers including the NHS, private individuals, and employers, expanding access to clinically validated care outside traditional in-person settings.

CareflowConnect creates a real-time clinical communications network which transforms how healthcare teams work together to improve patient safety and outcomes.